Eric Kristian Szczesniak, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Apt. 409, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-0533 |
Thomas H Kay, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. Paul J Gruszka, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. Bruce J Thoma, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Anthony C Levenda, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
David J Musgrave, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. James A Malayter, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 601 Gateway Blvd, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-0533 |
Nikola Nenadovich, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. Tyler Charles Miller, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 |
Anton A Thompkins, M.D. Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Aaron G Anderson, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. Michael C Leland, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. Michael Denz, D.O. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
News Archive
U.S. Department of Health and Human Services Secretary Kathleen Sebelius and Attorney General Eric Holder will discuss the Obama Administration's efforts to fight fraud using new tools provided by the Affordable Care Act at a press conference on Thursday, May 13, 2010, at 4:00 p.m. EDT. HHS and DOJ officials will also release a new report on fraud prevention and enforcement efforts.
No matter what age you are, surgery can be a scary thing. Knowing you are in good hands, though, can help soothe fears. K. Hovnanian Children's Hospital at Jersey Shore University Medical Center offers a comprehensive child-friendly, family-oriented program that includes surgical specialties, dentistry, general surgery, neurosurgery, ophthalmology, ENT, orthopedic surgery and urology.
Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of origin and migrate throughout the body.
Launched in 1988, the Global Polio Eradication Initiative (GPEI) stands out as one of the largest, internationally coordinated global public health major projects conducted to date, with cumulative spending of over $16.5 billion for 1988-2018, according to the World Health Organization.
The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 9 days ago